Atlas Trials

Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis

Clinical trial NCT02402491 · UNKNOWN

Trial details

NCT number
NCT02402491
Sponsor
Beijing Anzhen Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Percutaneous Coronary Intervention
Start date
2013-01-01
Primary completion
2015-06-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.